Viridian Therapeutics
VRDN
VRDN
170 hedge funds and large institutions have $1.32B invested in Viridian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 176 → 170 (-6)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
70% less call options, than puts
Call options by funds: $1.81M | Put options by funds: $5.96M
Holders
170
Holding in Top 10
10
Calls
$1.81M
Puts
$5.96M
Top Buyers
| 1 | +$23.7M | |
| 2 | +$17.3M | |
| 3 | +$16.4M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$8.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.61M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$10.1M | |
| 3 | -$6.07M | |
| 4 |
Goldman Sachs
New York
|
-$4.5M |
| 5 |
Renaissance Technologies
New York
|
-$4.32M |